Quantinno Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.47M Buy
964,490
+514,238
+114% +$2.68M 0.01% 1189
2025
Q4
$2.25M Buy
450,252
+183,038
+68% +$953K ﹤0.01% 1321
2025
Q3
$1.35M Buy
267,214
+155,227
+139% +$684K ﹤0.01% 1355
2025
Q2
$483K Buy
111,987
+18,303
+20% +$90.5K ﹤0.01% 1670
2025
Q1
$565K Buy
93,684
+66,386
+243% +$336K ﹤0.01% 1336
2024
Q4
$108K Sell
27,298
-4,694
-15% -$21K ﹤0.01% 1608
2024
Q3
$187K Buy
31,992
+8,338
+35% +$41.1K ﹤0.01% 1390
2024
Q2
$102K Buy
+23,654
New +$113K ﹤0.01% 1292
2024
Q1
Sell
-68,401
Closed -$336K 1222
2023
Q4
$336K Buy
68,401
+41,183
+151% +$202K 0.01% 929
2023
Q3
$148K Buy
27,218
+9,960
+58% +$79.8K 0.01% 993
2023
Q2
$160K Buy
+17,258
New +$146K 0.01% 889
2023
Q1
Sell
-25,618
Closed -$285K 879
2022
Q4
$285K Buy
+25,618
New +$298K 0.02% 705

Other funds holding MPT

Quantinno Capital Management's MPT Position: Q1 2026 in Review

Quantinno Capital Management increased its Medical Properties Trust (MPT) stake by 114% in Q1 2026, buying an estimated $2.68M and bringing the position to 964,490 shares worth $4.47M. The position accounts for 0.01% of the portfolio, ranked #1189.

Quantinno Capital Management first reported a position in MPT in Q4 2022 and has held it in 12 quarters since. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Quantinno Capital Management held 964,490 shares of Medical Properties Trust worth $4.47M as of Q1 2026.
  • Quantinno Capital Management bought 514,238 Medical Properties Trust shares in Q1 2026, an estimated $2.68M.
  • Medical Properties Trust made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1189 holding.
  • Quantinno Capital Management first reported a position in Medical Properties Trust in Q4 2022 and has held it in 12 quarters since.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.